Daniel C. Javitt

The Nathan S. Kline Institute, Orangeburg, NY, United States 
Cognitive Neuroscience and Schizophrenia
"Daniel Javitt"
Mean distance: 14.74 (cluster 23)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Martínez A, Tobe RH, Gaspar PA, et al. (2022) Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in Schizophrenia. Frontiers in Behavioral Neuroscience. 15: 787383
Patel GH, Arkin SC, Ruiz-Betancourt D, et al. (2021) Failure to engage the temporoparietal junction/posterior superior temporal sulcus predicts impaired naturalistic social cognition in schizophrenia. Brain : a Journal of Neurology
Balla A, Ginsberg SD, Abbas AI, et al. (2020) Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice. Biomarkers in Neuropsychiatry. 2
Sehatpour P, Avissar M, Kantrowitz JT, et al. (2020) Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia. Frontiers in Psychiatry. 11: 629144
Sehatpour P, Bassir Nia A, Adair D, et al. (2020) Multimodal Computational Modeling of Visual Object Recognition Deficits but Intact Repetition Priming in Schizophrenia. Frontiers in Psychiatry. 11: 547189
Sehatpour P, Donde C, Hoptman MJ, et al. (2020) Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning. Neuroimage. 117311
Dias EC, Sheridan H, Martínez A, et al. (2020) Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in Schizophrenia. Schizophrenia Bulletin
Moreno-Ortega M, Kangarlu A, Lee S, et al. (2020) Parcel-guided rTMS for depression. Translational Psychiatry. 10: 283
Patel GH, Arkin SC, Ruiz-Betancourt DR, et al. (2020) What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia. Psychological Medicine. 1-10
Kantrowitz JT, Grinband J, Goff DC, et al. (2020) Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
See more...